Quantitative Sensory Testing (QST) - Does assessing ... - TI Pharma

Contents
3.4. Number of sensory abnormalities in relation to neuropathic pain grading
3.5. Background pain in relation to neuropathic pain grading
4. Discussion
4.1. Clinical diagnoses and grading of neuropathic pain
4.2. Somatosensory function in healthy controls
4.3. Somatosensory function in neuropathic pain patients
4.3.1. Somatosensory function across the grading of neuropathic pain
4.4. Background pain, number of sensory abnormalities and neuropathic
pain grading
Acknowledgement
Chapter 4
A single QST parameter as a tool for mechanism-based investigation
of neuropathic pain
Abstract
1. Introduction
2. Method
2.1. Description of healthy controls
2.2. Description of the patient cohort
2.3. Quantitative sensory testing (QST)
2.4. Data analysis and statistics
2.4.1. Z-transformation of QST data
2.4.2. Stimulus-response function for MPS in patients
2.4.3. Statistical analyses
3. Results
3.1. Stimulus-response function in healthy subjects
3.2. Z-score transformation for MPS in patients
3.3. Differences in pattern of stimulus-response function
3.4. Clinical diagnoses of patients with MPS abnormalities and
different stimulus-response functions for pinpricks
4. Discussion
4.1. MPS abnormalities in neuropathic pain patients
4.2. Stimulus-response function for pinprick
4.3. QST for mechanism-based studies in neuropathic pain patients
Acknowledgement
59
59
60
61
62
62
63
63
64
65
66
67
68
68
69
69
69
69
70
70
70
70
71
71
73
74
75
75
77
78